edoc

Items where Author is "Heim, M."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008
Number of items: 14.

2014

Frentzen, A. and Anggakusuma, and Gurlevik, E. and Hueging, K. and Knocke, S. and Ginkel, C. and Brown, R. J. and Heim, M. and Dill, M. T. and Kroger, A. and Kalinke, U. and Kaderali, L. and Kuehnel, F. and Pietschmann, T.. (2014) Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells. Hepatology, Vol. 59, No. 1. pp. 78-88.

Frei, P. and Leucht, A. K. and Held, U. and Kofmehl, R. and Manser, C. N. and Schmitt, J. and Mertens, J. and Rau, M. and Baur, K. and Gerlach, T. and Negro, F. and Heim, M. and Moradpour, D. and Cerny, A. and Dufour, J. F. and Mullhaupt, B. and Geier, A.. (2014) Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-alpha and ribavirin in chronic hepatitis C virus patients. Liver international, Vol. 34, H. 4. pp. 551-557.

Haid, S. and Grethe, C. and Dill, M. T. and Heim, M. and Kaderali, L. and Pietschmann, T.. (2014) Isolate-dependent use of Claudins for cell entry by hepatitis C virus. Hepatology, Vol. 59, No. 1. pp. 24-34.

Thimme, R. and Heim, M. and Baumert, T. F. and Nassal, M. and Moradpour, D.. (2014) [Hepatitis B and C: from molecular virology to new antiviral therapies (part 2)]. Deutsche Medizinische Wochenschrift, 139 (15). pp. 778-782.

2013

Zeuzem, S. and Asselah, T. and Angus, P. and Zarski, J. P. and Larrey, D. and Mullhaupt, B. and Gane, E. and Schuchmann, M. and Lohse, A. W. and Pol, S. and Bronowicki, J. P. and Roberts, S. and Arasteh, K. and Zoulim, F. and Heim, M. and Stern, J. O. and Nehmiz, G. and Kukolj, G. and Bocher, W. O. and Mensa, F. J.. (2013) Faldaprevir (BI 201335), BI 207127 and ribavirin oral therapy for treatment-naive HCV genotype 1 : SOUND-C1 final results. Antiviral therapy, Vol. 18, H. 8. pp. 1015-1019.

Heim, M.. (2013) Reply to miR-122, IL28B genotype and the response to interferon in chronic hepatitis C virus infection. Nature reviews. Immunology, Vol. 13, H. 12. p. 902.

2012

Stickel, F. and Helbling, B. and Heim, M. and Geier, A. and Hirschi, C. and Terziroli, B. and Wehr, K. and De Gottardi, A. and Negro, F. and Gerlach, T.. (2012) Critical review of the use of erythropoietin in the treatment of anaemia during therapy for chronic hepatitis C. Journal of viral hepatitis, Vol. 19, H. 2. pp. 77-87.

2011

Zeuzem, S. and Asselah, T. and Angus, P. and Zarski, J. P. and Larrey, D. and Mullhaupt, B. and Gane, E. and Schuchmann, M. and Lohse, A. and Pol, S. and Bronowicki, J. P. and Roberts, S. and Arasteh, K. and Zoulim, F. and Heim, M. and Stern, J. O. and Kukolj, G. and Nehmiz, G. and Haefner, C. and Boecher, W. O.. (2011) Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection. Gastroenterology, Vol. 141, H. 6. pp. 2047-2055.

Semela, D. and Heim, M.. (2011) Hepatozellulares Karzinom. Therapeutische Umschau, Vol. 68, H. 4. pp. 213-217.

2010

Bareiss, D. and Semela, D. and Heim, M. and Terracciano, L. and Hunziker, S.. (2010) [44 year old gardener with lower back pain, myalgia and fever]. Schweizerische Rundschau für Medizin PRAXIS, Vol. 99, H. 2. pp. 127-132.

Sarrazin, C. and Berg, T. and Ross, R. S. and Schirmacher, P. and Wedemeyer, H. and Neumann, U. and Schmidt, H. H. and Spengler, U. and Wirth, S. and Kessler, H. H. and Peck-Radosavljevic, M. and Ferenci, P. and Vogel, W. and Moradpour, D. and Heim, M. and Cornberg, M. and Protzer, U. and Manns, M. P. and Fleig, W. E. and Dollinger, M. M. and Zeuzem, S.. (2010) [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Zeitschrift für Gastroenterologie, Vol. 48, H. 2. pp. 289-351.

2009

Dinges, S. and Morard, I. and Heim, M. and Dufour, J.-F. and Müllhaupt, B. and Giostra, E. and Clavien, P.-A. and Mentha, G. and Negro, F.. (2009) Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation. Transplant infectious disease : an official journal of the Transplantation Society, Vol. 11. pp. 33-39.

2008

Helbling, B. and Overbeck, K. and Gonvers, J.-J. and Malinverni, R. and Dufour, J.-F. and Borovicka, J. and Heim, M. and Cerny, A. and Negro, F. and Bucher, S. and Rickenbach, M. and Renner, E. L. and Mullhaupt, B.. (2008) Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection. Gut, Vol. 57, H. 11. pp. 1597-1603.

Giovanoli, O. and Heim, M. and Terracciano, L. and Bongartz, G. and Ledermann, H. P.. (2008) MRI of hepatic adenomatosis: initial observations with gadoxetic acid contrast agent in three patients. American journal of roentgenology, Vol. 190 , W290-293.

This list was generated on Wed Dec 2 23:39:07 2020 CET.